Cargando…
Senescent cells: A therapeutic target for osteoporosis
BACKGROUND: Osteoporosis (OP) is a prevalent disorder characterized by the loss of bone mass and the deterioration of bone microarchitecture. OP is attributed to various factors, including menopause (primary), ageing (primary) and the adverse effects of medications (secondary). Recently, cellular se...
Autores principales: | Wang, Tiantian, Huang, Shishu, He, Chengqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715365/ https://www.ncbi.nlm.nih.gov/pubmed/35986568 http://dx.doi.org/10.1111/cpr.13323 |
Ejemplares similares
-
Age Related Osteoporosis: Targeting Cellular Senescence
por: Föger-Samwald, Ursula, et al.
Publicado: (2022) -
Bone Aging, Cellular Senescence, and Osteoporosis
por: Pignolo, Robert J, et al.
Publicado: (2021) -
Senescent Cells: A Therapeutic Target in Cardiovascular Diseases
por: Suda, Masayoshi, et al.
Publicado: (2023) -
Targeting cellular senescence prevents glucocorticoid-induced bone loss through modulation of the DPP4-GLP-1 axis
por: Wang, Tiantian, et al.
Publicado: (2021) -
P2X7Rs: new therapeutic targets for osteoporosis
por: Huang, Haoyun, et al.
Publicado: (2022)